Factor 11 deficiency is a rare blood disorder that affects only a small percentage of people. It is caused by a deficiency of the clotting factor 11, which is responsible for the normal functioning of the blood clotting system. This disorder can cause serious health complications if not treated properly. In this article, we will take a closer look at the causes, symptoms, diagnosis, and treatment of factor 11 deficiency.
Factor 11 deficiency is a rare inherited disorder caused by a deficiency of the clotting factor 11. Factor 11 is a protein in the blood that helps the body form clots to stop bleeding. When factor 11 is deficient, the body is unable to form clots properly, leading to excessive bleeding. This disorder is also known as hemophilia C or Rosenthal syndrome.
Factor 11 deficiency is caused by a mutation in the F11 gene. This gene is responsible for producing factor 11. People who have this disorder inherit the mutation from one of their parents. In some cases, the mutation can be acquired due to environmental factors.
The symptoms of factor 11 deficiency vary from person to person, but they generally include excessive bleeding from cuts, bruises, and surgical procedures. People with factor 11 deficiency may also experience frequent nosebleeds, easy bruising, and prolonged bleeding after dental procedures.
Factor 11 deficiency is diagnosed through a blood test that measures the amount of factor 11 in the blood. If the amount is lower than normal, it indicates a deficiency. Your doctor may also order additional tests to rule out other causes of excessive bleeding.
The treatment of factor 11 deficiency depends on the severity of the disorder. Mild cases may not require any treatment, while more severe cases may require blood transfusions or injections of factor 11 concentrate. In some cases, surgery may be necessary to stop the bleeding.
Living with factor 11 deficiency can be difficult, but there are ways to manage the disorder. It is important to avoid activities that could cause excessive bleeding, such as contact sports and activities that involve sharp objects.
Factor 11 deficiency is a rare blood disorder that can cause serious health complications if not treated properly. It is caused by a mutation in the F11 gene and is usually inherited from one of the parents. The symptoms of factor 11 deficiency include excessive bleeding, easy bruising, and prolonged bleeding after dental procedures. Treatment for factor 11 deficiency depends on the severity of the disorder and may include blood transfusions, injections of factor 11 concentrate, or surgery.
1.
Risk of a second cancer after early breast cancer is low, say new findings
2.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
3.
Intractable cancers may respond better to treatment when using new radiation and high-performance computing.
4.
Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy
5.
Eight Doctors Killed in Brazil's Horrifying Plane Crash
1.
Exercise Rehabilitation in Hematologic Disease Survivorship
2.
Obesity is a major risk factor for cancer
3.
Exposure Modeling for Bispecific Antibodies: Scientific Foundations and Clinical Implications
4.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
5.
Dormant Tumor Cell Biomarkers for Early Oncologic Surveillance
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
2.
Recognizing General Warning Signs of Cancer
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
5.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation